Cytokines, such as the proinflammatory cytokines IL-12 and IFN-γ, play crucial roles in inhibiting the progression of breast cancer, so cytokine analysis of the serum and TME may provide important clues about the immunomodulatory effects of RH-Δompdc treatment. Here, IFNG is linked to breast cancer.